Immunohistochemical expression status of four biomarkers; hormone receptors [estrogen receptor (ER), progesterone receptor (PR)], human epidermal growth factor receptor (HER2), and Ki-67, are key determinants of breast cancer molecular subtyping [2]. The gene discussed is NR4A1; the disease is breast carcinoma.